Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005007576 | SCV005640703 | pathogenic | Polycystic kidney disease, adult type | 2024-04-04 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV005007576 | SCV006059939 | pathogenic | Polycystic kidney disease, adult type | 2024-02-08 | criteria provided, single submitter | clinical testing | The PKD1 c.74dup p.(Gly27ArgfsTer87) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected. To our knowledge, this variant has not been reported in the peer-reviewed literature. This variant is not observed in version 2.1.1 or version 4.0.0 of the Genome Aggregation Database. This variant has been shown to segregate with disease in this family. Based on the available evidence, this variant is classified as pathogenic for autosomal dominant polycystic kidney disease. |